IP Verse

Zaklady Farmaceutyczne Polpharma competitive analysis

Latest oppositions filed by Zaklady Farmaceutyczne Polpharma

Explore patent oppositions filed by Zaklady Farmaceutyczne Polpharma against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jun 25, 2026
Patent NumberTitleApplicantOpposition Date
EP4212152
Sacubitril-Valsartan Dosage Regimen For Treating Heart FailureNOVARTISJan 23, 2026
EP3689365
Use Of Long-Acting Glp-1 PeptidesNOVO NORDISKDec 24, 2025
EP3539540
Pharmaceutical Composition, Methods For Treating And Uses ThereofBOEHRINGER INGELHEIMSep 17, 2025
EP4321157
New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)NOVARTISJul 23, 2025
EP3529360
Methods For Preventing Cardiovascular Events Through Proprotein Convertase Subtilisin Kexin 9 (Pcsk9) Protein ReductionNOVARTISJan 15, 2025
EP3474820
Glp-1 Compositions And Uses ThereofNOVO NORDISKNov 7, 2024
EP2395968
Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIMOct 10, 2024
EP3595667
Pharmaceutical Compositions Comprising A Jak InhibitorALFASIGMASep 20, 2024
EP3999643
Methods Of Treating Or Preventing Spinal Muscular AtrophyBIOGEN MAAug 20, 2024
EP3270909
Fixed Dose Combinations Comprising Etc1002 And One Or More Statins For Treating Or Reducing Cardiovascular RiskESPERION THERAPEUTICSJul 31, 2024

Latest PTAB cases involving Zaklady Farmaceutyczne Polpharma

Discover the latest PTAB cases involving Zaklady Farmaceutyczne Polpharma, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Zaklady Farmaceutyczne Polpharma with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jun 25, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
POLPHARMA34 - - -
BOEHRINGER INGELHEIM3321789
BRISTOL MYERS SQUIBB IRELAND - 52 - -
NOVARTIS6526 - 21